申请人:SK CHEMICALS CO., LTD.
公开号:US20160009677A1
公开(公告)日:2016-01-14
The present invention relates to: a compound selected from the group consisting of a tricyclic compound having the structure of formula I, a pharmaceutically acceptable salt, an isomer, a solvate and a precursor thereof; and a use thereof. The compound effectively controls GPR40, and thus, can be effectively used for the prophylaxis or treatment of diseases associated with GPR40, for example, diabetes and many other diseases.
本发明涉及以下内容:一种从具有I式结构的三环化合物、药学上可接受的盐、异构体、溶剂化物和其前体中选择的化合物;以及其用途。该化合物有效地控制GPR40,因此,可以有效地用于预防或治疗与GPR40相关的疾病,例如糖尿病和许多其他疾病。